COVID-19 Monoclonal Antibodies: Understanding Treatment & Effectiveness

Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens, such as viruses and bacteria. They are designed to bind to specific proteins on the surface of a pathogen, preventing it from entering or infecting cells.

For COVID-19, monoclonal antibodies have been developed to target the spike protein of the SARS-CoV-2 virus, which is responsible for the virus's ability to enter human cells. These antibodies can help block the virus from entering cells and prevent infection.

Monoclonal antibodies for COVID-19 are typically administered through an intravenous (IV) infusion. They are usually given to people who are at high risk of developing severe COVID-19, such as those with weakened immune systems or certain underlying medical conditions.

The use of monoclonal antibodies for COVID-19 has been shown to be effective in preventing hospitalization and death in people at high risk of severe disease. However, monoclonal antibodies are not a substitute for vaccination. Vaccination remains the best way to protect yourself from COVID-19.

Here are some important things to know about monoclonal antibodies for COVID-19:

* They are not a cure for COVID-19. They are designed to help prevent people from developing severe disease.

* They are not effective against all variants of the SARS-CoV-2 virus.

* They are not a substitute for vaccination. Vaccination remains the best way to protect yourself from COVID-19.

* Monoclonal antibodies are typically administered through an IV infusion. They are usually given to people who are at high risk of developing severe COVID-19.

If you have questions about monoclonal antibodies for COVID-19, talk to your doctor.